NIMODIPINE
Drugs in Pregnancy and Lactation.
Welcome to Pregnancy Without PoundsYou absolutely DO NOT have to pack on extra pregnancy weight.
Get a FREE subscription to my Pregnancy Exercise, Diet and Beauty Tips Newsletter sent to you each week.Sign In! |
Name: NIMODIPINE
Class: Calcium Channel Blocker
Risk Factor: CM
Fetal Risk Summary
Nimodipine is a calcium channel-blocking agent used to reduce the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage after rupture of congenital aneurysms. The drug produced a dose-related increase in the incidence of malformations and stunted fetuses in rabbits (1). In rats, nimodipine was embryotoxic, causing resorptions and stunted fetal growth, but except for skeletal variations, caused no malformations (1).
Two cases have been described in which the drug was used as a cerebral vasodilator for the treatment of eclampsia complicated by cerebral vasospasm and edema, but in both cases delivery of the fetus had occurred a few hours before initiation of treatment (2,3). The investigators recommended that nimodipine not be used in combination with magnesium sulfate because of the risk for maternal heart block (3).
A prospective, multicenter cohort study of 78 women (81 outcomes; 3 sets of twins) who had 1st-trimester exposure to calcium channel blockers, including 11% to nimodipine, was reported in 1996 (4). Compared with controls, no increase in the risk of major congenital malformations was found.
Breast Feeding Summary
Nimodipine and its metabolites are concentrated in the milk of lactating rats (1). No reports describing the use of the drug during human lactation have been located.
References
- Product information. Nimotop. Bayer, 2000.
- Horn EH, Filshie M, Kerslake RW, Jaspan T, Worthington BS, Rubin PC. Widespread cerebral ischaemia treated with nimodipine in a patient with eclampsia. Br Med J 1990;301:794.
- Belfort MA, Carpenter RJ Jr, Kirshon B, Saade GR, Moise KJ Jr. The use of nimodipine in a patient with eclampsia: color flow Doppler demonstration of retinal artery relaxation. Am J Obstet Gynecol 1993;169:204–6.
- Magee LA, Schick B, Donnenfeld AE, Sage SR, Conover B, Cook L, McElhatton PR, Schmidt MA, Koren G. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996;174:823–8.
Q&A about Nimodipine
Nimodipine is a calcium channel blocker.
The rest of the info is on the website.
The Patient is a 60+ years old lady who was diagnosed to be suffering from Diabetes during a routine clinical examination at a followup session to her otherwise well controlled Hypertension >30years, she had been on Atenolol and Nifedipine. Currently she is on Atenolol and Nimodipine. A trial at Physiotherapy, simple analgesics excersize has not helped much. Her major complains now burn like pain in the feet with greater concentration at the heels. She is on oral hypoglycaemics plus diet modification her blood sugar levels are good bet 4-7mMol/L
Neurontin and Lyrica. Lyrica is a newer drug related to neurontin, but with fewer side effects. I'm not sure how they work. Another option is Cymbalta. It is an antidepressant that also happens to help with pain, including diabetic neuropathy.
The details of how drugs work in a person's body is sometimes unknown. For example, we know what nimodipine is and what its used for, but its actions are unknown. How is it safe then to actually prescribe a drug, when the course of action in one's body is unknown?

